$187 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SELECT SECTOR SPDR TRput | $6,391,000 | – | 100,000 | +100.0% | 3.41% | – | |
| ZBH | New | ZIMMER HLDGS INC | $5,028,000 | – | 50,000 | +100.0% | 2.69% | – |
| New | REGENERON PHARMACEUTICALSput | $3,605,000 | – | 10,000 | +100.0% | 1.93% | – | |
| New | UNITED THERAPEUTICS CORP DEL | $3,216,000 | – | 25,000 | +100.0% | 1.72% | – | |
| RCPT | New | RECEPTOS INC | $3,106,000 | – | 50,000 | +100.0% | 1.66% | – |
| New | PFIZER INC | $2,957,000 | – | 100,000 | +100.0% | 1.58% | – | |
| New | SANOFIcall | $2,822,000 | – | 50,000 | +100.0% | 1.51% | – | |
| HZNP | New | HORIZON PHARMA PLC | $2,702,000 | – | 220,000 | +100.0% | 1.44% | – |
| DXCM | New | DEXCOM INC | $2,600,000 | – | 65,000 | +100.0% | 1.39% | – |
| New | MERCK & CO INC NEWput | $2,371,000 | – | 40,000 | +100.0% | 1.27% | – | |
| ASPX | New | AUSPEX PHARMACEUTICALS INC | $2,310,000 | – | 90,000 | +100.0% | 1.23% | – |
| CMRX | New | CHIMERIX INC | $2,072,000 | – | 75,000 | +100.0% | 1.11% | – |
| AGN | New | ALLERGAN INC | $1,782,000 | – | 10,000 | +100.0% | 0.95% | – |
| PETX | New | ARATANA THERAPEUTICS INC | $1,506,000 | – | 150,000 | +100.0% | 0.80% | – |
| ARWR | New | ARROWHEAD RESH CORP | $1,330,000 | – | 90,000 | +100.0% | 0.71% | – |
| OSUR | New | ORASURE TECHNOLOGIES INC | $1,264,000 | – | 175,000 | +100.0% | 0.68% | – |
| ELOS | New | SYNERON MEDICAL LTD | $1,202,000 | – | 120,000 | +100.0% | 0.64% | – |
| New | CELLDEX THERAPEUTICS INC NEWcall | $972,000 | – | 75,000 | +100.0% | 0.52% | – | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $855,000 | – | 125,000 | +100.0% | 0.46% | – |
| SNY | New | SANOFIsponsored adr | $846,000 | – | 15,000 | +100.0% | 0.45% | – |
| New | GW PHARMACEUTICALS PLCcall | $809,000 | – | 10,000 | +100.0% | 0.43% | – | |
| New | WRIGHT MED GROUP INCcall | $758,000 | – | 25,000 | +100.0% | 0.40% | – | |
| New | AGIOS PHARMACEUTICALS INCput | $614,000 | – | 10,000 | +100.0% | 0.33% | – | |
| New | TORNIER N Vcall | $598,000 | – | 25,000 | +100.0% | 0.32% | – | |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $410,000 | – | 50,000 | +100.0% | 0.22% | – |
| New | ENTEROMEDICS INCcall | $87,000 | – | 70,000 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.